Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series.

Autor: Chamboux M; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre-Val de Loire, University Hospital of Tours, 37000 Tours, France., Simon C; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre-Val de Loire, University Hospital of Tours, 37000 Tours, France., Beau-Salinas F; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre-Val de Loire, University Hospital of Tours, 37000 Tours, France., Maurier A; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre-Val de Loire, University Hospital of Tours, 37000 Tours, France., Agier MS; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre-Val de Loire, University Hospital of Tours, 37000 Tours, France., Thillard EM; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre-Val de Loire, University Hospital of Tours, 37000 Tours, France., Largeau B; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre-Val de Loire, University Hospital of Tours, 37000 Tours, France., Jonville-Bera AP; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre-Val de Loire, University Hospital of Tours, 37000 Tours, France. Electronic address: jonville-bera@chu-tours.fr.

Publikováno v: Therapie [Therapie] 2023 Nov-Dec; Vol. 78 (6), pp. 705-709. Date of Electronic Publication: 2023 Feb 16.

Drug Points: High Doses of Deferiprone May Be Associated with Cerebellar Syndrome

Autor: Beau-Salinas, F., Guitteny, M. A., Donadieu, J., Jonville-Bera, A. P., Autret-Leca, E.

Publikováno v: BMJ: British Medical Journal, 2009 Mar . 338(7695), 653-653.

Externí odkaz: https://www.jstor.org/stable/20512348

Response to Letter "Only blames SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out".

Autor: Chamboux M; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre Val de Loire, University Hospital of Tours, 37000 Tours, France., Simon C; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre Val de Loire, University Hospital of Tours, 37000 Tours, France., Beau-Salinas F; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre Val de Loire, University Hospital of Tours, 37000 Tours, France., Maurier A; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre Val de Loire, University Hospital of Tours, 37000 Tours, France., Agier MS; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre Val de Loire, University Hospital of Tours, 37000 Tours, France., Thillard EM; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre Val de Loire, University Hospital of Tours, 37000 Tours, France., Largeau B; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre Val de Loire, University Hospital of Tours, 37000 Tours, France., Jonville-Bera AP; Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre Val de Loire, University Hospital of Tours, 37000 Tours, France. Electronic address: jonville-bera@chu-tours.fr.

Publikováno v: Therapie [Therapie] 2023 Jul-Aug; Vol. 78 (4), pp. 464-465. Date of Electronic Publication: 2023 May 25.

Pharmacovigilance des vaccins

Autor: Autret-Leca, E., Bensouda-Grimaldi, L., Jonville-Béra, A.P., Beau-Salinas, F.

Publikováno v: In Archives de pédiatrie 2006 13(2):175-180

Info-médicaments

Autor: Simon, C., Lengelle, C., Agier, M.-S., Beau-Salinas, F., Vrignaud, L., Jonville-Béra, A.-P.

Publikováno v: In Archives de pédiatrie November 2017 24(11):1150-1157